Relationship between antioxidant and renoprotective activity of olmesartan

• In: Clinical Biology Posters
• At: Lisbon (Portugal) (2010)
• Type: Poster
• Poster code: CBS-P-012
• By: KADOWAKI, Daisuke (Kumamoto University, Kumamoto, Japan)
• Co-author(s): Makoto, Anraku (Fukuyama University, FUKUYAMA, Japan)
  Yuka, Tasaki (Kumamoto University, KUMAMOTO, Japan)
  Kazuaki, Taguchi (Kumamoto University, KUMAMOTO, Japan)
  Kazuki, Shimoishi (Kumamoto University, KUMAMOTO, Japan)
  Ayaka, Suenaga (Kumamoto University, KUMAMOTO, Japan)
  Hiroshi, Watanabe (Kumamoto University, KUMAMOTO, Japan)
  Hakaru, Seo (Sojo University, KUMAMOTO, Japan)
  Sumio, Hirata (Kumamoto University, KUMAMOTO, Japan)
  Toru, Maruyama (Kumamoto University, KUMAMOTO, Japan)
  Masaki, Otagiri (Sojo University, KUMAMOTO, Japan)
  
• Abstract:

  Angiotensin II type 1 receptor blockers, which are used in the treatment of hypertension, inhibit the rennin-angiotensin system. In addition to their ability to lower blood pressure (BP), these compounds have also been reported to protect organs, such as kidney and heart. Although the mechanisms of these protective effects are not fully..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login